跳至主要内容
临床试验/NCT01519375
NCT01519375已完成不适用

Cross-sectional, Observational Real Life Study on NSAIDs Treated Patients With Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis: Assessment of Patient Adherence to PPI Treatment

AstraZeneca1 个研究点 分布在 1 个国家目标入组 102 人开始时间: 2012年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
102
试验地点
1
主要终点
Patient reported adherence to PPI treatment on actual days of NSAID treatment.

研究概览

简要总结

The primary objective of this cross-sectional observational real life study is to investigate the patient reported adherence to PPI, when prescribed as prevention of NSAID associated GI Ulcers to patients prescribed a NSAID. Patients included have Osteoarthritis, Rheumatoid Arthritis or Ankylosing Spondylitis. Adherence will be assessed by patient questionnaires.

详细描述

Cross-sectional, observational Real Life study on NSAIDs treated patients with Osteoarthritis, Rheumatoid Arthritis and Ankylosing Spondylitis: Assessment of patient adherence to PPI treatment

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Confirmed diagnosis (documented in the medical record) of OA, RA or AS
  • Prescription of oral NSAID treatment for OA, RA or AS, where low dose is not sufficient
  • Prescription of PPI for prevention of NSAID associated GI ulcers, with instruction to take PPI same day as when taking NSAID.

排除标准

  • Participating in any clinical trial involving PPI or NSAID
  • Patients prescribed PPI as acute treatment of GI events or symptoms within 8 weeks
  • Inability to complete PROs

结局指标

主要结局

Patient reported adherence to PPI treatment on actual days of NSAID treatment.

时间窗: 7 days

次要结局

  • Patient adherence to prescribed ASA treatment.(7 days)
  • Proportion of patients with reported adherence ≤ 80%.(7 days)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验